In this
editorial in the San Jose Mercury News, David Magnus and Art Caplan argue that with the passing of California’s prop. 71, it is long past time to stop worrying about the President’s policies or the tired issue of whether ex vivo embryos are people. The new stem cell debate is going to be about when the science justifies moving to clinical trials, worries about the therapeutic misconception and conflicts of interest. I know I am not the only one who feels like i’ve gone back in time–substitute enthusiasm for stem cell research for gene therapy. We argue in this piece that we should learn some lessons from that experience.
Labels: Art Caplan, California, David Magnus, Proposition 71, stem cell research, therapeutic misconceptions
